Adaptimmune Therapeutics Plc (ADAPY)

0.0299 -0.01 (-14.57%) USD  |  OTCM  |  Dec 23, 16:00
More

Adaptimmune Therapeutics SG&A Expense (TTM): 90.49M for June 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ADAPY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 5.354M
NuCana Plc 9.964M
Autolus Therapeutics Plc 129.58M
Mereo BioPharma Group Plc 25.26M
Bicycle Therapeutics Plc 80.05M